Drug Profile
RES 7011
Alternative Names: KF 20704; RES-701-1Latest Information Update: 13 Oct 2006
Price :
$50
*
At a glance
- Originator Kyowa Hakko
- Class Antiasthmatics; Antihypertensives
- Mechanism of Action Endothelin B receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Respiratory tract disorders
Most Recent Events
- 13 Oct 2006 Discontinued - Preclinical for Respiratory tract disorders in Japan (unspecified route)
- 12 Jun 2001 No-Development-Reported for Respiratory tract disorders in Japan (Unknown route)
- 02 Sep 1996 Preclinical development for Respiratory tract disorders in Japan (Unknown route)